Summary

Report Scope
The routine health screening market presents a vast and promising opportunity as it responds to evolving healthcare trends and societal needs. With an increasing emphasis on preventive healthcare, routine health screenings have become instrumental in detecting potential health issues at early stages. The market’s expansion is propelled by the rising incidence of non-communicable diseases, such as diabetes and cardiovascular disorders, coupled with the aging global population, necessitating proactive health management strategies. Technological advancements, including innovations in diagnostic tools and the integration of artificial intelligence, enhance the accuracy and accessibility of screenings, catering to a broader demographic. The aftermath of the COVID-19 pandemic has further underscored the importance of regular health check-ups, reinforcing the significance of routine health screenings.
Additionally, incorporating these screenings into corporate wellness programs and the trend toward personalized medicine further amplifies the market’s potential. The routine health screening market is poised for substantial expansion, playing a pivotal role in the proactive and personalized management of individual health globally. This report presents insights into this market’s current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges, and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies, and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.
Report Includes
- 37 data tables and 39 additional tables
- An overview of the global market for routine health screening
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by test type, sample type, technology, and region
- A look at recent innovations, technological advances, and product launches in the market
- Analysis of the industry’s regulatory framework and policies
- A discussion of ESG challenges and practices in the routine health screening industry
- An analysis of the key companies’ market shares, proprietary technologies, alliances, and other strategies
- A discussion of key patents
- Profiles of the leading players, including Quest Diagnostics, Laboratory Corporation of America Holdings, Sonic Healthcare Ltd., Eurofins Scientific, and SYNLAB AG

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Cholesterol Test
Diabetes Test
Blood Pressure Test
Cancer Screening Test
Prenatal Testing
Vision and Hearing Screening
Bone Density Test
Thyroid Profile Test
Essential Nutrients Check
Others
Chapter 3 Market Dynamics
Factors Affecting the Routine Health Screening Market
Market Drivers
Advancements in Screening Technologies
Growing Prevalence of Chronic Diseases
Growing Health Consciousness
Increasing Healthcare Spending
Market Restraints
High Costs Associated with Routine Health Screening
Psychological Barriers
Lack of Awareness and Acceptability in Low and Middle Income Countries
Market Challenges
False Positive and False Negative Screening Test Results
Declining Reimbursement
Market Opportunities
Adoption of AI in Routine Health Screening
Expansive Opportunities in Emerging Economies
Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Routine Health Screening Market, by Test Type
Cholesterol Screening
Diabetes Screening
Blood Pressure Test
Cancer Screening
Prenatal Screening
Vision and Hearing Screening
Bone Density Test
Thyroid Profile Test
Essential Nutrients Tests
Others
Routine Health Screening Market, by Sample Type
Overview
Blood-Based Sample
Urine-Based Sample
Imaging Sample
Other Samples
Routine Health Screening Market, by Technology
Overview
QPCR (Quantitative Polymerase Chain Reaction)
Q-FISH (Quantitative Fluorescence In Situ Hybridization) Technology
Immunoassays
Medical Imaging
STELA (Single Telomere Length Analysis)
Other Technologies
Geographic Breakdown
Routine Health Screening Market, by Region
North America
Asia-Pacific
Europe
Rest of the World
Chapter 5 Emerging and Upcoming Technologies in the Market
Introduction
Emerging and Upcoming Technologies
Deep Phenotyping Technologies
Digital Health Interventions
Digital Precision Medicine
Wearable Devices and Remote Monitoring
Multicancer Detection (MCDs) Assays
Artificial Intelligence in Routine Health Screening
5G-Enabled Devices
Genetics Testing
Technological Concerns in the Routine Health Screening Market
Efficacy Data
Data Privacy
Regulatory Landscape
Supply Chain Challenges
Recent Developments
Chapter 6 ESG Development
Introduction
Sustainability in Routine Health Screening Industry
WHO Global Action Plan
BCC Research Viewpoint
Chapter 7 Competitive Landscape
Mergers, Acquisitions and Collaborations
Manufacturer and Service Provider Market Share Analysis
Strategic Alliances
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ARUP LABORATORIES
CERBA HEALTHCARE
EUROFINS SCIENTIFIC
EXACT SCIENCE CORP.
OPKO HEALTH INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
NATERA INC.
QUEST DIAGNOSTICS INC.
SONIC HEALTHCARE LTD.
SYNLAB AG